Search Results - "Charlton, Carmen L"

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies by Charlton, Carmen L, Kanji, Jamil N, Johal, Kam, Bailey, Ashley, Plitt, Sabrina S, MacDonald, Clayton, Kunst, Andrea, Buss, Emily, Burnes, Laura E, Fonseca, Kevin, Berenger, Byron M, Schnabl, Kareena, Hu, Jia, Stokes, William, Zelyas, Nathan, Tipples, Graham

“…Coronavirus disease (COVID) serological tests are essential to determine the overall seroprevalence of a population and to facilitate exposure estimates within…”
Get full text

Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies by Shoute, Lian C. T., Abdelrasoul, Gaser N., Ma, Yuhao, Duarte, Pedro A., Edwards, Cole, Zhuo, Ran, Zeng, Jie, Feng, Yiwei, Charlton, Carmen L., Kanji, Jamil N., Babiuk, Shawn, Chen, Jie

“…The COVID-19 pandemic has posed enormous challenges for existing diagnostic tools to detect and monitor pathogens. Therefore, there is a need to develop…”
Get full text

Identifying gaps in the treatment of hepatitis C in patients co-infected with HIV in Edmonton, Alberta by Round, Jessica M., Savaryn, Bohdan, Plitt, Sabrina S., Shafran, Stephen D., Charlton, Carmen L.

“…With the availability of direct-acting antivirals, Hepatitis C (HCV) is now considered a treatable disease. Patients who are co-infected with human…”
Get full text

Faradaic Impedimetric Immunosensor for Label-Free Point-of-Care Detection of COVID-19 Antibodies Using Gold-Interdigitated Electrode Array by Shoute, Lian C T, Charlton, Carmen L, Kanji, Jamil N, Babiuk, Shawn, Babiuk, Lorne, Chen, Jie

“…Label-free electrochemical biosensors have many desirable characteristics in terms of miniaturization, scalability, digitization, and other attributes…”
Get full text

Baseline assessment of and linkage to care for newly diagnosed patients with chronic hepatitis B by Remington, Tamara Leah, Osman, Mariam, Simmonds, Kimberley, Charlton, Carmen L, Doucette, Karen

“…Patients with chronic hepatitis B (CHB) are at risk of complications and require lifelong monitoring. We evaluated the care of newly diagnosed CHB patients…”
Get full text

Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic by Charlton, Carmen L, Nguyen, Leonard T, Bailey, Ashley, Fenton, Jayne, Plitt, Sabrina S, Marohn, Carol, Lau, Cheryl, Hinshaw, Deena, Lutsiak, Christie, Simmonds, Kimberley, Kanji, Jamil N, Zelyas, Nathan, Lee, Nelson, Mengel, Michael, Tipples, Graham

“…We systematically evaluated SARS-CoV-2 IgG positivity in a provincial cohort to understand the local epidemiology of COVID-19 and support evidence-based public…”
Get full text

A low-cost initiative to reduce duplicate hepatitis B virus serological testing by Passi, Amrit, Plitt, Sabrina S., Charlton, Carmen L.

“…Currently, multiple clinical laboratories provide serological testing for hepatitis B virus (HBV) in Alberta, Canada. Concerns were raised regarding single…”
Get full text

How to determine protective immunity in the post-vaccine era by Charlton, Carmen L., Lai, Florence Y., Dover, Douglas C.

“…The ability to determine an individual's susceptibility to infection relies heavily on the assay used, and the ability to correlate results of the assay to a…”
Get full text

Reply to: “Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany” by Thompson, L. Alexa, Charlton, Carmen L.

Get full text

Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers by O’Neil, Conar R, Congly, Stephen E, Rose, M. Sarah, Lee, Samuel S, Borman, Meredith A, Charlton, Carmen L, Osiowy, Carla, Swain, Mark G, Burak, Kelly W, Coffin, Carla S

“…AbstractIntroduction. Quantitative hepatitis B surface antigen (qHBsAg) combined with HBV DNA may be useful for predicting chronic hepatitis B (CHB) activity…”
Get full text

A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection by Taylor, Sean C, Hurst, Beth, Charlton, Carmen L, Bailey, Ashley, Kanji, Jamil N, McCarthy, Mary K, Morrison, Thomas E, Huey, Leah, Annen, Kyle, DomBourian, Melkon G, Knight, Vijaya

“…Many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology tests have proven to be less accurate than expected and do not assess antibody…”
Get full text

Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections by Charlton, Carmen L, Babady, Esther, Ginocchio, Christine C, Hatchette, Todd F, Jerris, Robert C, Li, Yan, Loeffelholz, Mike, McCarter, Yvette S, Miller, Melissa B, Novak-Weekley, Susan, Schuetz, Audrey N, Tang, Yi-Wei, Widen, Ray, Drews, Steven J

“…Respiratory viral infections are associated with a wide range of acute syndromes and infectious disease processes in children and adults worldwide. Many…”
Get full text

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies by Hiebert, Joanne, Zubach, Vanessa, Charlton, Carmen L, Fenton, Jayne, Tipples, Graham A, Fonseca, Kevin, Severini, Alberto

“…The World Health Organization (WHO) has targeted measles for global eradication through mass immunization. For effective monitoring of eradication targets,…”
Get full text

Evaluation and comparison of risk-based and universal prenatal HCV screening programs in Alberta, Canada by Thompson, L. Alexa, Plitt, Sabrina S., Doucette, Karen, Coffin, Carla S., Klein, Kristin B., Robinson, Joan L., Charlton, Carmen L.

“…Canadian clinical practice guidelines currently recommend risk-based screening for HCV in pregnant individuals. However, no provinces or territories have ever…”
Get full text

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies by Hiebert, Joanne, Zubach, Vanessa, Charlton, Carmen L, Fenton, Jayne, Tipples, Graham A, Fonseca, Kevin, Severini, Alberto

“…Rubella and congenital rubella syndrome are caused by the rubella virus and are preventable through vaccination, making disease eradication possible…”
Get full text

Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints by Bobenchik, April M, Deak, Eszter, Hindler, Janet A, Charlton, Carmen L, Humphries, Romney M

“…Vitek 2 (bioMérieux Inc., Durham, NC) is a widely used commercial antimicrobial susceptibility test system. We compared the MIC results obtained using the…”
Get full text

Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints by Bobenchik, April M, Deak, Eszter, Hindler, Janet A, Charlton, Carmen L, Humphries, Romney M

“…The performances of Vitek 2 AST-GN69 and AST-XN06 cards were compared to Clinical and Laboratory Standards Institute (CLSI) reference broth microdilution (BMD)…”
Get full text

What’s in a number? The value of titers as routine proof of immunity for medical students by Charlton, Carmen L., Bailey, Ashley-Nicole M., Thompson, L. Alexa, Kanji, Jamil N., Marshall, Natalie C.

“…•Medical school admission requirements do not match national vaccination guidelines.•Observed increase in requests for quantitative proof-of-immunity…”
Get full text

Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests by Kanji, Jamil N., Bailey, Ashley, Fenton, Jayne, Ling, Sean H., Rivera, Rafael, Plitt, Sabrina, Sligl, Wendy I., Taylor, Sean, Turnbull, LeeAnn, Tipples, Graham, Charlton, Carmen L.

“…With rapid approval of SARS-CoV-2 vaccines, the ability of clinical laboratories to detect vaccine-induced antibodies with available high-throughput commercial…”
Get full text

How To Prepare for the Unexpected: a Public Health Laboratory Response by Charlton, Carmen L, Hull, Noah, Sloma, Cari Roark, Bonifas, Mary, Johnson, Matthew, Strain, Anna K, Wolford, Tyler, Staley, Sherrie, Perkins, Carey, Razzaque, Rafia, Courtney, Colleen, Bind, Eric P

“…Public health laboratories (PHLs) continue to face internal and external challenges to their abilities to provide successful, timely responses to public health…”
Get full text